Campaign Unavailable

Antibiotic resistance is a growing crisis in human medicine, and the use of important human drugs in animal agriculture unnecessarily places our health at risk. The Food and Drug Administration (FDA) is currently considering an application by drug company Schering-Plough to allow an antibiotic called cefquinome to be used to treat cattle respiratory infections. Cefquinome is from the class of drugs known as “fourth-generation cephalosporins”—drugs that are highly valued in human medicine to treat life-threatening infections. Widespread use of cefquinome in cattle could drive human bacterial resistance to this critical class of drugs.

Please sign this petition to Schering-Plough CEO Fred Hassan urging the company to withdraw its application for use of cefquinome in cattle.